NCT05070247 2026-01-22
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Phase 1/2 Terminated
Takeda
Peking University First Hospital
Montefiore Medical Center
Halozyme Therapeutics
Canadian Cancer Trials Group
H. Lee Moffitt Cancer Center and Research Institute
Università Vita-Salute San Raffaele
National Cancer Institute (NCI)